BioSpace News Archive

Provided an update on the Company’s strategic and financial outlook as a standalone company following the recent termination of its merger agreement with Idera Pharmaceuticals, Inc.

The lawsuit alleges patent infringement of DUSA’s patents covering DUSA’s product for topical solution, 20% used with DUSA’s BLU-U Blue Light Photodynamic Therapy Illuminator.

Synvaza reduces pain associated with erosive or ulcerative oral lesions

UNICANCER to Bring Next Generation Radiotherapy to Centre Georges-François Leclerc (CGFL)

This is a co-formulation with Halozyme’s proprietary recombinant human hyaluronidase enzyme, which is approved and marketed under the Herceptin® SC brand in many countries outside the U.S.

Neurotrope, Inc. is announcing that it has established its Scientific Advisory Board (SAB) comprised of experts in the fields of AD and other Neurological diseases.

BioMarin Pharmaceutical Inc. announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 2, at 4:30 p.m. ET

According to the Corporate Whistleblower Center, “We are urging a physical therapist who is employed by a hospital, skilled nursing facility, or a rehab center that is forcing patients to have extra PT, or medically unnecessary physical therapy as another way to rip off Medicare-Medicaid to call us anytime at 866-714-6466.

The trial, which will be launched in the upcoming month, will be conducted in 25 medical centers in the US and Israel.

Hoy Health LLC announced the launch of a new way to buy medications at low cost, HoyRX.